Colon Cancer 2022: Updates from Three Clinical Trials
Presentation by David Hsu, MD, PhD, Duke University Medical Center Despite ongoing improvements in screening, diagnosis, and treatment,...
top of page
- Nov 1, 2022
- 2 min
Maintenance Therapy in Advanced Ovarian Cancer: A Benefit of Continued PARP Inhibitor Treatment
Dr Premal Thaker, from Washington University School of Medicine, reports from the ASCO Direct Series, St. Louis 2022. The ATHENA trial...
- Oct 27, 2022
- 3 min
What is a “Cancer Survivor”, and Should I Use Acetaminophen with My Immuno-oncology Agent?
Dr. Shayma Kazmi, from Penn Medicine-Abramson Cancer Center, breaks down three hot topics during the 2022 ASCO Direct Philadelphia...
- Oct 27, 2022
- 4 min
Supplements, Cannabis, and Acupuncture – What’s New in Cancer Survivorship?
Dr. Shayma Kazmi, from Penn Medicine-Abramson Cancer Center, breaks down three hot topics during the 2022 ASCO Direct Philadelphia...
- Oct 27, 2022
- 1 min
New in Metastatic Breast Cancer: What Your Patients Need to Know About the TROPiCS-02 Trial
Data Presented by Dr. Lee Schwartzberg from Renown Cancer Center at the 2022 ASCO Direct Las Vegas Conference. TROPiCS-02 was a phase III...
- Oct 27, 2022
- 2 min
New in Metastatic Breast Cancer: What Your Patients Need to Know About the DESTINY-Breast04 Trial
Data Presented by Dr. Lee Schwartzberg from Renown Cancer Center at the 2022 ASCO Direct Las Vegas Conference. DESTINY-Breast04, or DB04,...
bottom of page